AstraZeneca and Amgen’s asthma biologic approved in the US

AstraZeneca and Amgen’s asthma biologic approved in the US

Submitted by admin on December 20, 2021 - 11:08am
Source: 
Biopharma Reporter
News Tags: 
AstraZeneca
Amgen
Tezspire
FDA
severe asthma
Headline: 
AstraZeneca and Amgen’s asthma biologic approved in the US
snippet: 

AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.

Do Not Allow Advertisers to Use My Personal information